Skip to main content
Clinical Trials/NCT01020526
NCT01020526
Completed
Phase 4

A 6-month, Open-label, Safety Trial Of Pregabalin In Adolescent Patients With Fibromyalgia

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.25 sites in 3 countries63 target enrollmentSeptember 2010
ConditionsFibromyalgia
Interventionspregabalin

Overview

Phase
Phase 4
Intervention
pregabalin
Conditions
Fibromyalgia
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Enrollment
63
Locations
25
Primary Endpoint
Change From Baseline in Pain Numeric Rating Scale by Week
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The main purpose of this study is to evaluate the long-term safety of pregabalin in adolescent patients who participated in the previous fibromyalgia study (A0081180) and who wish to recieve open-label pregabalin

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
June 2015
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients must have met the inclusion criteria for the preceding fibromyalgia Study A0081180, and have received pregabalin/placebo under double-blind conditions.

Exclusion Criteria

  • Patients may not participate in the study if they experienced a serious adverse event during the previous fibromyalgia study A0081180 which was determined to be related to the study medication by the investigator or sponsor.

Arms & Interventions

Pregabalin

Intervention: pregabalin

Outcomes

Primary Outcomes

Change From Baseline in Pain Numeric Rating Scale by Week

Time Frame: Baseline, Weeks 3, 8, 16, 24 and Last Visit.

The weekly pain numeric rating scale (Weekly Pain NRS) consists of an 11-point NRS ranging from 0 (no pain) to 10 (worst possible pain), where higher scores indicate worse pain. Participants chose the number that best described the pain during the last week. Negative change indicates improvement.

Study Sites (25)

Loading locations...

Similar Trials